Healthcare (SH:603313)2026-01-30 09:25Financial Performance - The company expects a net profit attributable to shareholders of between 90 million and 130 million yuan for the year 2025, marking a turnaround from a loss in the previous year[3]. - The estimated net profit after deducting non-recurring gains and losses is projected to be between 50 million and 70 million yuan for 2025[4]. - In the previous year, the company reported a net loss attributable to shareholders of 151.42 million yuan and a total profit of -164.25 million yuan[5]. - The earnings forecast indicates a significant improvement compared to the previous year's performance, reflecting a strategic shift in operations[4]. Asset Management - The company has reduced asset impairment losses compared to the previous year, contributing to the expected profit[7]. Market Strategy - The company has strengthened its domestic and international market expansion, enhancing brand development and online business growth, leading to stable revenue growth[7]. Earnings Forecast - The earnings forecast is based on preliminary calculations and has not been audited, with final figures to be confirmed in the audited annual report[9]. - There is uncertainty regarding the final compensation amount for accounts receivable from CVB, Inc., which may affect the earnings forecast[8]. - The company has communicated with its auditors regarding the uncertainties and currently does not foresee major discrepancies[8]. - Investors are advised to be cautious of potential risks that may impact the accuracy of the earnings forecast[8].